- Fellowship - Mayo Clinic (2017-2018), Advanced Radiation Oncology
- Residency - McGill University Health Centre (2012-2017), Radiation Oncology
- Medical School - Université Laval, Canada (2007-2012)
Aurelie Garant, M.D.
Director of Brachytherapy Program
- Radiation Oncology
- Genitourinary Cancer
- Kidney Cancer
New Patient Appointment Accepting Virtual Visits or 214-645-8525
Biography
Aurelie Garant, M.D., is an Associate Professor of Radiation Oncology and Director of the Brachytherapy Program at UT Southwestern Medical Center. She is board certified in radiation oncology by the American Board of Radiology.
Dr. Garant earned her medical degree at Université Laval, Canada, followed by a residency at McGill University Health Centre and a fellowship at Mayo Clinic in advanced radiation oncology. In 2015, she received the McGill University Residency Program award, and in 2017, the John D. Earle Fellowship at the Mayo Clinic.
In 2020, Dr. Garant received a Diploma of the Royal College of Physicians and Surgeons of Canada for focused competency in brachytherapy.
Education & Training
Honors & Awards
- ARRO Educator of the Year 2023
- Texas Super Doctors, Rising Star 2023
- Texas Super Doctors, Rising Star 2022
- Texas Super Doctors, Rising Star 2021
- Texas Super Doctors, Rising Star 2020
- NIH Kidney Cancer SPORE Career Enhancement Program Award 2019
- UT Southwestern Leaders Emerging in Academic Departments (LEAD) Course: Class of 2019 2019
- Reviewer (by invitation), International Journal of Radiation Oncology Biology Physics 2018
- American Brachytherapy Society Prostate LDR/HDR Scholarship 2018
- John D. Earle Radiation Oncology Fellowship Fund, Mayo Clinic, Rochester MN 2017-2018
- McGill University Residency Program Award – Scholar 2015-2016
- CIHR Travel Award Recipient for research presented abroad 2015
- McGill University Residency Program Award – Collaborator/Manager 2014-2015
- Chief Resident, Radiation Oncology Residency Program, McGill University, Canada 2014-2015
Books & Publications
-
Books
-
Surgical Techniques in Rectal Cancer in Neoadjuvant Radiotherapy
Vuong T, Garant A (2018), New York City, Springer -
Current Therapy in Colon and Rectal Surgery in Cancer of the Rectum: Neoadjuvant Therapy
Vuong T, Garant A, Niazi T (2016), Amsterdam, Elsevier Sciences
-
Surgical Techniques in Rectal Cancer in Neoadjuvant Radiotherapy
-
Publications
-
Optimising local treatment decisions for rectal cancer
Jethwa KR, Aujla KS, Garant A The Lancet Gastroenterology and Hepatology 2024 Sep 9 779-781 -
Performance deterioration of deep learning models after clinical deployment: a case study with auto-segmentation for definitive prostate cancer radiotherapy
Wang B, Dohopolski M, Bai T, Wu J, Hannan R, Desai N, Garant A, Yang D, Nguyen D, Lin MH, Timmerman R, Wang X, Jiang SB Machine Learning: Science and Technology 2024 Jun 5 -
BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy
Vitzthum LK, Surucu M, Gensheimer MF, Kovalchuk N, Han B, Pham D, Chang D, Shirvani SM, Aksoy D, Maniyedath A, Narayanan M, Da Silva AJ, Mazin S, Feghali KA, Iyengar P, Dan T, Pompos A, Timmerman R, Öz O, Cai B, Garant A International Journal of Radiation Oncology Biology Physics 2024 Apr 118 1172-1180 -
F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer
Solanki AA, Yoo RK, Adams W, Davicioni E, Mysz ML, Shea S, Gupta GN, Showalter T, Garant A, Hentz C, Farooq A, Baldea K, Small W, Harkenrider MM BJU international 2024 Feb 133 188-196 -
The role of the radiologist in the prostate cancer multidisciplinary conference
Costa DN, Nguyen N, Garant A, Meng X, Courtney KD, Shah RB, Pedrosa I Abdominal Radiology 2024 -
Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapy
Liang X, Yen A, Bai T, Godley A, Shen C, Wu J, Meng B, Lin MH, Medin P, Yan Y, Owrangi M, Desai N, Hannan R, Garant A, Jiang S, Deng J Medical physics 2023 Dec 50 7368-7382 -
The Crying Need for a Better Response Assessment in Rectal Cancer
Amintas S, Giraud N, Fernandez B, Dupin C, Denost Q, Garant A, Frulio N, Smith D, Rullier A, Rullier E, Vuong T, Dabernat S, Vendrely V Current treatment options in oncology 2023 Nov 24 1507-1523 -
Organ sparing treatment for penile cancer using a 3D-printed high-dose-rate brachytherapy applicator
Lee HH, Chiu TD, Hrycushko B, Xiong Z, Hudak S, Woldu S, Mauck R, Corwin T, Meng X, Margulis V, Desai N, Folkert MR, Garant A Brachytherapy 2023 Sep 22 580-585 -
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer
Hannan R, McLaughlin MF, Pop LM, Pedrosa I, Kapur P, Garant A, Ahn C, Christie A, Zhu J, Wang T, Robles L, Durakoglugil D, Woldu S, Margulis V, Gahan J, Brugarolas J, Timmerman R, Cadeddu J European urology 2023 Sep 84 275-286 -
Preliminary Evaluation of PTV Margins for Online Adaptive Radiation Therapy of the Prostatic Fossa
Morgan HE, Wang K, Yan Y, Desai N, Hannan R, Chambers E, Cai B, Lin MH, Sher DJ, Wang J, Wang AZ, Jiang S, Timmerman R, Park C“, Garant A Practical Radiation Oncology 2023 Jul 13 e345-e353 -
Evaluation of fan-beam kilovoltage computed tomography image quality on a novel biological-guided radiotherapy platform
Zhuang T, Gibbard G, Duan X, Tan J, Park Y, Lin MH, Sun Z, Oderinde OM, Lu W, Reynolds Jr. RR, Godley A, Pompos A, Dan T, Garant A, Iyengar P, Timmerman R, Jiang S, Cai B Physics and Imaging in Radiation Oncology 2023 Apr 26 -
Artificial Intelligence–Empowered Radiation Oncology Residency Education
Kwon YS, Dohopolski M, Morgan H, Garant A, Sher D, Rahimi A, Sanford NN, Vo D, Albuquerque K, Kumar K, Timmerman R, Jiang SB Practical Radiation Oncology 2023 Jan 13 8-10 -
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer
Hannan R, Christensen M, Christie A, Garant A, Pedrosa I, Robles L, Mannala S, Wang C, Hammers H, Arafat W, Courtney K, Bowman IA, Sher D, Ahn C, Cole S, Choy H, Timmerman R, Brugarolas J European Urology Oncology 2022 Dec 5 695-703 -
Image-Guided Brachytherapy for Rectal Cancer: Reviewing the Past Two Decades of Clinical Investigation
Vuong T, Garant A, Vendrely V, Nout R, Martin AG, Enger SA, Podgorsak E, Moftah B, Devic S Cancers 2022 Oct 14 -
Clinical applications of high dose rate endorectal brachytherapy for patients with rectal cancer
Vuong T, Garant A, Vendrely V, Martin AG, Devic S Cancer/Radiotherapie 2022 Oct 26 879-883 -
Case Report: Adaptive radiotherapy in the radiation salvage of prostate cancer
Montalvo SK, Meng B, Lin MH, Park C, Desai NB, Hannan R, Garant A Frontiers in Oncology 2022 Aug 12 -
MORPHEUS Phase II–III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results
Garant A, Vasilevsky CA, Boutros M, Khosrow-Khavar F, Kavan P, Diec H, Des Groseilliers S, Faria J, Ferland E, Pelsser V, Martin AG, Devic S, Vuong T Cancers 2022 Aug 14 -
Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
Hannan R, Dohopolski MJ, Pop LM, Mannala S, Watumull L, Womack KB, Gao A, Garant A, Arriaga YE, Bowman I, Chung J, Wang J, Ariizumi K, Ahn C, Timmerman R, Courtney K Biomedicines 2022 Jun 10 -
SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial
Hannan R, Salamekh S, Desai NB, Garant A, Folkert MR, Costa DN, Mannala S, Ahn C, Mohamad O, Laine AM, Kim DW, Dickinson T, Raj GV, Shah RB, Wang J, Jia X, Choy H, Roehrborn CG, Lotan Y, Timmerman RD International Journal of Radiation Oncology Biology Physics 2022 Jun 113 290-301 -
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer
Hannan R, Christensen M, Hammers H, Christie A, Paulman B, Lin D, Garant A, Arafat W, Courtney K, Bowman I, Cole S, Sher D, Ahn C, Choy H, Timmerman R, Brugarolas J European Urology Oncology 2022 Apr 5 216-224 -
Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
Chen L, Gannavarapu BS, Desai NB, Folkert MR, Dohopolski M, Gao A, Ahn C, Cadeddu J, Bagrodia A, Woldu S, Raj GV, Roehrborn C, Lotan Y, Timmerman RD, Garant A, Hannan R Frontiers in Oncology 2022 Feb 12 -
PSA-Net: Deep learning–based physician style–aware segmentation network for postoperative prostate cancer clinical target volumes
Balagopal A, Morgan H, Dohopolski M, Timmerman R, Shan J, Heitjan DF, Liu W, Nguyen D, Hannan R, Garant A, Desai N, Jiang S Artificial Intelligence in Medicine 2021 Nov 121 -
Metastasis-directed radiation therapy after radical cystectomy for bladder cancer
Miranda AF, Howard JM, McLaughlin M, Meng X, Clinton T, Şanli Ö, Garant A, Bagrodia A, Margulis V, Lotan Y, Hannan R, Desai N, Woldu SL Urologic Oncology: Seminars and Original Investigations 2021 Nov 39 790.e1-790.e7 -
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R Advances in Radiation Oncology 2021 Sep 6 -
A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy
Balagopal A, Nguyen D, Morgan H, Weng Y, Dohopolski M, Lin MH, Barkousaraie AS, Gonzalez Y, Garant A, Desai N, Hannan R, Jiang S Medical Image Analysis 2021 Aug 72 -
A Multi-Institutional Analysis of Radiation Dosimetric Predictors of Toxicity After Trimodality Therapy for Esophageal Cancer
Garant A, Spears G, Routman D, Whitaker T, Liao Z, Harmsen W, Liu A, Haddock M, Hallemeier C, Lin S, Merrell K Practical Radiation Oncology 2021 Jul 11 e415-e425 -
Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy
McLaughlin MF, Folkert MR, Timmerman RD, Hannan R, Garant A, Hudak SJ, Costa DN, Desai NB Advances in Radiation Oncology 2021 Jul 6 -
Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC
All S, Garant A, Hannan R Seminars in Radiation Oncology 2021 Jul 31 227-234 -
Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial
Garant A, Kavan P, Martin AG, Azoulay L, Vendrely V, Lavoie C, Vasilevsky CA, Boutros M, Faria J, Nguyen TN, Ferland E, Des Groseilliers S, Cloutier AS, Diec H, Drolet S, Richard C, Batist G, Vuong T Radiotherapy and Oncology 2021 Feb 155 237-245 -
Evolving Brachytherapy Boost in Prostate Cancer in the Era of Hypofractionation
Desai NB, Garant A, Hannan R, Folkert MR International Journal of Radiation Oncology Biology Physics 2020 Nov 108 914-916 -
The reintroduction of radiotherapy into the integrated management of kidney cancer
Dohopolski M, Hannan R, Wardak Z, Hammers H, Garant A Cancer Journal 2020 Sep 26 448-459 -
Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer
Garant A, Magnan S, Devic S, Martin AG, Boutros M, Vasilevsky CA, Ferland S, Bujold A, DesGroseilliers S, Sebajang H, Richard C, Vuong T International Journal of Radiation Oncology Biology Physics 2019 Dec 105 1005-1011 -
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer
Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon S, Merrell KW, Haddock MG, Hallemeier CL Practical Radiation Oncology 2019 Nov 9 410-417 -
Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer
Atluri PS, Gannavarapu BS, Timmerman RD, Garant A, Hannan R, Folkert MR, Desai NB Practical Radiation Oncology 2019 Nov 9 e528-e533 -
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer
Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I, Singla N, Hammers H, Courtney K, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R International Journal of Radiation Oncology Biology Physics 2019 Oct 105 367-375 -
Optimization of HDRBT boost dose delivery for patients with rectal cancer
Devic S, Bekerat H, Garant A, Vuong T Brachytherapy 2019 Jul 18 559-563 -
A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
Routman DM, Garant A, Lester SC, Day CN, Harmsen WS, Sanheuza CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW Advances in Radiation Oncology 2019 Jan 4 63-69 -
Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy?
Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T International Journal of Colorectal Disease 2018 Jun 33 727-733 -
Neoadjuvant radiotherapy
Vuong T, Garant A 2018 Jan 65-76 -
Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: A systematic review
Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, Vuong T Critical Reviews in Oncology/Hematology 2017 Dec 120 86-92 -
Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non–small-cell Lung Cancer
Guilbault C, Garant A, Faria S, Owen S, Ofiara L, Duclos M, Hirsh V, Kopek N Clinical lung cancer 2017 Sep 18 565-571 -
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases
Siddiqui MR, Simillis C, Hunter C, Chand M, Bhoday J, Garant A, Vuong T, Artho G, Rasheed S, Tekkis P, Abulafi AM, Brown G British journal of cancer 2017 Jun 116 1513-1519 -
EGFR and K-ras gene mutation status in squamous cell anal carcinoma: A role for concurrent radiation and EGFR inhibitors
Paliga A, Onerheim R, Gologan A, Chong G, Spatz A, Niazi T, Garant A, MacHeto D, Alcindor T, Vuong T British journal of cancer 2012 Nov 107 1864-1868 -
Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment
Hunter CJ, Garant A, Vuong T, Artho G, Lisbona R, Tekkis P, Abulafi M, Brown G Annals of Surgical Oncology 2012 Apr 19 1199-1205 -
Late Anastomotic Dehiscence during Bevacizumab Therapy for Patients with Colorectal Cancer
Garant A, Des Groseilliers S, Martin L, Ferland É, Vuong T Clinical Oncology 2011 Sep 23 497-498 -
Risk of Hypogonadism From Scatter Radiation During Pelvic Radiation in Male Patients With Rectal Cancer
Yau I, Vuong T, Garant A, Ducruet T, Doran P, Faria S, Liberman S, Richard C, Letellier F, Charlebois P, Loungnarath R, Stein B, Devic S International Journal of Radiation Oncology Biology Physics 2009 Aug 74 1481-1486
-
Optimising local treatment decisions for rectal cancer
Research
- RCC spine metastases
- Bladder cancer in women
- Prostate cancer protocols
- Rectal cancer in elderly patients
Clinical Focus
- Genitourinary Cancer
- Kidney Cancer
- Prostate Cancer
- Brachytherapy
- Penile Cancer
- Skin Cancer
Results: 1 Locations
University Hospital Radiation Oncology Clinic
at Radiation Oncology Building 2280 Inwood RoadDallas, Texas 75390 214-645-8525 Directions to University Hospital Radiation Oncology Clinic
New Patient Appointment Accepting Virtual Visits or 214-645-8525